Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
eli lilly
4
×
life sciences
national blog main
boston blog main
clinical trials
fda
indiana blog main
indiana top stories
avapritinib
blueprint medicines
boston
boston top stories
europe blog main
europe top stories
genentech
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
roche
san francisco blog main
san francisco top stories
selpercatinib
thyroid cancer
alprazolam
amgen
boehringer ingelheim
cancer
cancer drugs
capmatinib
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
cstone pharmaceuticals
deals
drug enforcement administration
empagliflozin
europe
european medicines agency
What
approval
4
×
drug
fda
blueprint
cancer
eli
lilly
medicines
ret
acute
address
addresses
approves
bid
boehringer
candidate
carries
causes
certain
condition
currently
decades
designed
diabetes
expand
fallen
friday
genetic
giant
giving
ingelheim
lasmiditan
latest
lilly’s
marketed
marketing
medication
medicine’s
migraine
muscle
Language
unset
4
×
Current search:
approval
×
unset
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
